NO921595L - Superaktive grf analoger - Google Patents

Superaktive grf analoger

Info

Publication number
NO921595L
NO921595L NO92921595A NO921595A NO921595L NO 921595 L NO921595 L NO 921595L NO 92921595 A NO92921595 A NO 92921595A NO 921595 A NO921595 A NO 921595A NO 921595 L NO921595 L NO 921595L
Authority
NO
Norway
Prior art keywords
grf
provides
analogs
compounds
growth hormone
Prior art date
Application number
NO92921595A
Other languages
English (en)
Norwegian (no)
Other versions
NO921595D0 (no
Inventor
Richard Dennis Dimarchi
Mark Louis Heiman
James Edwin Shields
David Lee Smiley
David Ira Wickiser
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO921595D0 publication Critical patent/NO921595D0/no
Publication of NO921595L publication Critical patent/NO921595L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/60Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Steering-Linkage Mechanisms And Four-Wheel Steering (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
NO92921595A 1991-04-26 1992-04-24 Superaktive grf analoger NO921595L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69209091A 1991-04-26 1991-04-26

Publications (2)

Publication Number Publication Date
NO921595D0 NO921595D0 (no) 1992-04-24
NO921595L true NO921595L (no) 1992-10-27

Family

ID=24779221

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921595A NO921595L (no) 1991-04-26 1992-04-24 Superaktive grf analoger

Country Status (24)

Country Link
EP (1) EP0511003B1 (es)
JP (1) JPH05279388A (es)
KR (1) KR100233804B1 (es)
CN (1) CN1068123A (es)
AT (1) ATE178073T1 (es)
AU (1) AU1513292A (es)
BR (1) BR9201512A (es)
CA (1) CA2067304A1 (es)
CZ (1) CZ285567B6 (es)
DE (1) DE69228717T2 (es)
DK (1) DK0511003T3 (es)
ES (1) ES2129430T3 (es)
FI (1) FI921855A (es)
GR (1) GR3030459T3 (es)
HU (1) HUT64589A (es)
IE (1) IE921338A1 (es)
IL (1) IL101620A (es)
MX (1) MX9201878A (es)
NO (1) NO921595L (es)
NZ (1) NZ242459A (es)
SG (1) SG46364A1 (es)
TW (1) TW360661B (es)
YU (1) YU44292A (es)
ZA (1) ZA922746B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453418A (en) * 1988-03-07 1995-09-26 Eli Lilly And Company Ractopamine and growth hormone combinations
WO1994001451A2 (en) * 1992-07-13 1994-01-20 Bionebraska, Inc. Method for modification of recombinant polypeptides
PT828758E (pt) * 1995-05-26 2002-02-28 Theratechnologies Inc Analogos quimericos de corpo gordo-pro-grf com potencia biologica aumentada
EP0766966A3 (en) * 1995-09-08 2001-02-28 Eli Lilly And Company Method of treating insulin resistance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628043A (en) * 1983-04-26 1986-12-09 The Salk Institute For Biological Studies Hypothalamic GRF agonists
US4626523A (en) * 1983-09-13 1986-12-02 The Salk Institute For Biological Studies GRF analogs II
US4528190A (en) * 1983-10-25 1985-07-09 The Salk Institute For Biological Studies GRF Analogs IV
CA1271600A (en) * 1985-01-07 1990-07-10 David Howard Coy Growth hormone-releasing peptides and method of treating mammals therewith

Also Published As

Publication number Publication date
EP0511003B1 (en) 1999-03-24
SG46364A1 (en) 1998-02-20
CS121192A3 (en) 1992-11-18
IL101620A0 (en) 1992-12-30
CN1068123A (zh) 1993-01-20
YU44292A (sh) 1994-06-24
HUT64589A (en) 1994-01-28
FI921855A (fi) 1992-10-27
DK0511003T3 (da) 1999-05-25
KR920019817A (ko) 1992-11-20
CA2067304A1 (en) 1992-10-27
IL101620A (en) 1996-08-04
TW360661B (en) 1999-06-11
ES2129430T3 (es) 1999-06-16
CZ285567B6 (cs) 1999-09-15
JPH05279388A (ja) 1993-10-26
ZA922746B (en) 1992-12-30
AU1513292A (en) 1992-10-29
GR3030459T3 (en) 1999-10-29
AU690264B2 (en) 1998-04-23
BR9201512A (pt) 1992-12-01
KR100233804B1 (ko) 1999-12-01
HU9201399D0 (en) 1992-08-28
NO921595D0 (no) 1992-04-24
IE921338A1 (en) 1992-11-04
ATE178073T1 (de) 1999-04-15
NZ242459A (en) 1993-12-23
DE69228717D1 (de) 1999-04-29
AU2333495A (en) 1995-09-14
DE69228717T2 (de) 1999-08-19
FI921855A0 (fi) 1992-04-24
MX9201878A (es) 1992-10-01
EP0511003A1 (en) 1992-10-28

Similar Documents

Publication Publication Date Title
NO905472L (no) Insulinanaloger fra menneske og blandinger som inneholderdem.
EA199901025A1 (ru) Пептидные аналоги паратиреоидного гормона
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
ES2101833T3 (es) Utilizacion de igf-i humano.
DE3585556D1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
ATE154641T1 (de) Neues physiologisch aktives schweinepeptid (cnp- 53)
NO843195L (no) Veksthormon-frigjoerende peptider, anvendelse derav og fremgangsmaate for fremstilling derav
KR927002373A (ko) 성장 호르몬 분비 활성을 갖는 폴리펩타이드 화합물
MX9203175A (es) Composicion de implante que contiene un peptido, polipeptido o proteina biologicamente activa y procedimiento para su preparacion.
FI921855A0 (fi) Superaktiva grf-analoger.
AU2254588A (en) Biologically active segments of several growth hormones
EP0821004A4 (en) NOVEL PEPTIDES AND MEDICINES FOR BONE DISEASES CONTAINING THESE PEPTIDES AS ACTIVE INGREDIENT
NO881661D0 (no) Humane rhinoviruspeptider.
GB2195641A (en) Polypeptide with interleukin-2 activity
MX9707904A (es) Analogos del factor de liberacion de la hormona del crecimiento.